RE: Clinical trial31 Jan 2020 17:22
No point trying to blind us with science, Forge. If Med was any good FUM would surely be chasing it up, but they're putting all their eggs in one basket, Dermasys. As far as I can tell, they don't have a specific patent for the version of Dermasys that they used as the placebo, as they claim on the website it is "highly customisable". They have a few patents on it, and obviously they've registered the trademark, but an actual patent for the trial version? I've researched this a bit, and it was the subject of a lot of debate a couple of years ago. In 2017 a poster on one of these board claimed that Barder had emailed him and confirmed there was no specific patent, which is surprising for their core product.
I try to ignore the science because in my experience the way an AIM company manages themselves is more important than the efficaciousness of the product., so I'm hoping they sort themselves out and get the SP up a bit so I can bale without too much of a loss. Sad but true, and sorry to sound like a deramper.